Impact of the atherosclerotic process in patients with diabetes.

作者: R. W. Nesto , M. K. Rutter

DOI: 10.1007/S005920200022

关键词:

摘要: Between 120 and 140 million people suffer from diabetes mellitus (type 1 type 2) worldwide, this number may well double by the year 2025. Patients with are at increased risk of atherosclerosis its clinical sequelae: coronary, peripheral vascular, cerebrovascular diseases. Concurrently, most common cause death in persons is myocardial infarction. The pathogenesis, progression, epidemiology atherosclerotic disease distinct patients diabetes. Atherosclerosis can develop much earlier life, an accelerated rate, compared non-diabetic individuals. One factors responsible for related to atherogenic lipid profile pathobiological processes that transforming dormant plaques into active rupture-prone be enhanced as well. It follows a major challenge treatment reduce disease. third National Cholesterol Education Program (NCEP) report recently recommended management dyslipidaemia should aggressive those established coronary heart (CHD). NCEP Adult Treatment Panel III guidelines recommend statins elevated CHD.

参考文章(28)
Z Makita, R Bucala, H Shiiki, T Nishino, K Dohi, Y Nakamura, H Vlassara, T Kagoshima, Y Horii, Y Sakaguchi, Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. American Journal of Pathology. ,vol. 143, pp. 1649- 1656 ,(1993)
George Steiner, Atherosclerosis, the Major Complication of Diabetes Advances in Experimental Medicine and Biology. ,vol. 189, pp. 277- 297 ,(1985) , 10.1007/978-1-4757-1850-8_15
Cecil M. Burchfiel, Dwayne M. Reed, Ellen B. Marcus, Jack P. Strong, Takuji Hayashi, Association of Diabetes Mellitus with Coronary Atherosclerosis and Myocardial Lesions An Autopsy Study from the Honolulu Heart Program American Journal of Epidemiology. ,vol. 137, pp. 1328- 1340 ,(1993) , 10.1093/OXFORDJOURNALS.AJE.A116642
Pedro R. Moreno, Alvaro M. Murcia, Igor F. Palacios, Miltiadis N. Leon, Victor H. Bernardi, Valentín Fuster, John T. Fallon, Coronary Composition and Macrophage Infiltration in Atherectomy Specimens From Patients With Diabetes Mellitus Circulation. ,vol. 102, pp. 2180- 2184 ,(2000) , 10.1161/01.CIR.102.18.2180
Richard D. Siegel, Adrienne Cupples, Ernst J. Schaefer, Peter W.F. Wilson, LIPOPROTEINS, APOLIPOPROTEINS, AND LOW-DENSITY LIPOPROTEIN SIZE AMONG DIABETICS IN THE FRAMINGHAM OFFSPRING STUDY Metabolism-clinical and Experimental. ,vol. 45, pp. 1267- 1272 ,(1996) , 10.1016/S0026-0495(96)90246-2
Alberto Corsini, Franco Bernini, Pierangelo Quarato, Elena Donetti, Stefano Bellosta, Remo Fumagalli, Rodolfo Paoletti, Maurizio R. Soma, Non-Lipid-Related Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors The Cardiology. ,vol. 87, pp. 458- 468 ,(1996) , 10.1159/000177139
Klas Malmberg, Salim Yusuf, Hertzel C Gerstein, Joanne Brown, Feng Zhao, David Hunt, Leopoldo Piegas, James Calvin, Matyas Keltai, Andrzej Budaj, for the OASIS Registry Investigators, None, Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry Circulation. ,vol. 102, pp. 1014- 1019 ,(2000) , 10.1161/01.CIR.102.9.1014
J. Stamler, O. Vaccaro, J. D. Neaton, D. Wentworth, , Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. ,vol. 16, pp. 434- 444 ,(1993) , 10.2337/DIACARE.16.2.434
H. Miettinen, S. Lehto, V. Salomaa, M. Mahonen, M. Niemela, S. M. Haffner, K. Pyorala, J. Tuomilehto, , Impact of Diabetes on Mortality After the First Myocardial Infarction Diabetes Care. ,vol. 21, pp. 69- 75 ,(1998) , 10.2337/DIACARE.21.1.69
J.Koudy Williams, Galina K Sukhova, David M Herrington, Peter Libby, Pravastatin Has Cholesterol-Lowering Independent Effects on the Artery Wall of Atherosclerotic Monkeys Journal of the American College of Cardiology. ,vol. 31, pp. 684- 691 ,(1998) , 10.1016/S0735-1097(97)00537-8